Evidence map›Paper›PMID 37621696›Full record

ArticleACS sustainable chemistry & engineering2023

A Customized Bayesian Algorithm to Optimize Enzyme-Catalyzed Reactions.

Ryo Tachibana, Kailin Zhang, Zhi Zou, Simon Burgener, Thomas R Ward

Abstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ryo TachibanaDepartment of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058, Basel, Switzerland.ORCID https://orcid.org/0000-0002-7229-3370
Kailin ZhangDepartment of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058, Basel, Switzerland.
Zhi ZouDepartment of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058, Basel, Switzerland.
Simon BurgenerDepartment of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058, Basel, Switzerland.ORCID https://orcid.org/0000-0003-3703-168X
Thomas R WardDepartment of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, CH-4058, Basel, Switzerland.ORCID https://orcid.org/0000-0001-8602-5468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Design of experiments (DoE) plays an important role in optimizing the catalytic performance of chemical reactions. The most commonly used DoE relies on the response surface methodology (RSM) to model the variable space of experimental conditions with the fewest number of experiments. However, the RSM leads to an exponential increase in the number of required experiments as the number of variables increases. Herein we describe a Bayesian optimization algorithm (BOA) to optimize the continuous parameters (e.g., temperature, reaction time, reactant and enzyme concentrations, etc.) of enzyme-catalyzed reactions with the aim of maximizing performance. Compared to existing Bayesian optimization methods, we propose an improved algorithm that leads to better results under limited resources and time for experiments. To validate the versatility of the BOA, we benchmarked its performance with biocatalytic C-C bond formation and amination for the optimization of the turnover number. Gratifyingly, up to 80% improvement compared to RSM and up to 360% improvement vs previous Bayesian optimization algorithms were obtained. Importantly, this strategy enabled simultaneous optimization of both the enzyme's activity and selectivity for cross-benzoin condensation.

Identifiers

PMID37621696
PMCPMC10445256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.